Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2025

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Unveils Progress on CNM-Au8(R), Eyes Potential Fast-Track FDA Approval

Posted on March 21, 2025 by MissionIR

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is actively advancing … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

Posted on March 21, 2025 by MissionIR

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent accomplishments and financial results for the year ended Dec. 31, 2024. “We … Continue reading →

Posted in Soligenix Inc. SNGX | Leave a comment

Thumzup Media Corp. (NASDAQ: TZUP) Boosts Shareholder Value with Share Buyback

Posted on March 21, 2025 by MissionIR

Social media branding and marketing innovator Thumzup (NASDAQ: TZUP) continues building, helping shareholders after its uplisting to the Nasdaq exchange, announcing recently that board members have approved a stock buyback program of up to $1 million in shares and the company has … Continue reading →

Posted in Thumzup Media Corp. TZUP | Leave a comment

MissionIRNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Fuels Explosive Growth with Disruptive AdTech Platform

Posted on March 19, 2025 by MissionIR

Thumzup (NASDAQ: TZUP) is leveraging its proprietary social media marketing platform, AdTech, which drives influencers to catapult the effectiveness of small-business advertising. Having achieved a growth rate of over 200% CAGR, Thumzup now serves more than 700 clients, with projections to … Continue reading →

Posted in Thumzup Media Corp. TZUP | Leave a comment

Clene Inc.’s (NASDAQ: CLNN) CNM-Au8(R) Delivers Significant Survival Benefits in New Analyses of Healey ALS Platform Trial Data

Posted on March 19, 2025 by MissionIR

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), has released … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Why Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’

Posted on March 18, 2025 by MissionIR

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its … Continue reading →

Posted in Soligenix Inc. SNGX | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates Quantum Supremacy on a Real-World Problem

Posted on March 18, 2025 by MissionIR

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has confirmed a major milestone in quantum computing, demonstrating quantum computational supremacy on a practical, real-world problem. A newly published, peer-reviewed paper in Science validates … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Present at BIO-Europe Spring 2025

Posted on March 17, 2025 by MissionIR

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and contract development and manufacturing (CDMO) services, announced its participation in the BIO-Europe Spring 2025 conference from March 17-19 in Milan, Italy. The company’s leadership … Continue reading →

Posted in Scinai Immunotherapeutics Ltd. SCNI | Leave a comment

Thumzup Media (NASDAQ: TZUP) Already Tops 700 Businesses Using New Social Media Marketing Solution

Posted on March 14, 2025 by MissionIR

Social media marketing has grown exponentially since the turn of the century, when some 25 million social media identities existed worldwide. Last year’s Digital 2024: Global Overview Report by DataReportal (https://ibn.fm/zfypb) found that there were now well over 5 billion … Continue reading →

Posted in Thumzup Media Corp. TZUP | Leave a comment

MissionIRNewsBreaks – D-Wave Reports Fourth Quarter and Year-End 2024 Results

Posted on March 14, 2025 by MissionIR

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has announced its financial results for fourth quarter and year-end 2024, with a 128% year-over-year increase in bookings, reaching $23.9 million in bookings for the … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment